These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 15172744

  • 1. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
    Lahiri DK, Sambamurti K, Bennett DA.
    Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744
    [Abstract] [Full Text] [Related]

  • 2. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
    Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST.
    Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
    [Abstract] [Full Text] [Related]

  • 3. ApoE genotype accounts for the vast majority of AD risk and AD pathology.
    Raber J, Huang Y, Ashford JW.
    Neurobiol Aging; 2004 Aug; 25(5):641-50. PubMed ID: 15172743
    [Abstract] [Full Text] [Related]

  • 4. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F, Solfrizzi V, D'Introno A, Capurso C, Colacicco AM, Torres F, Altomare E, Capurso A.
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [Abstract] [Full Text] [Related]

  • 5. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.
    Fallin D, Gauntlett AC, Scibelli P, Cai X, Duara R, Gold M, Crawford F, Mullan M.
    Genet Epidemiol; 1997 Sep; 14(3):299-305. PubMed ID: 9181358
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
    Maloney B, Ge YW, Alley GM, Lahiri DK.
    J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI.
    Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
    [Abstract] [Full Text] [Related]

  • 9. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.
    Butters MA, Sweet RA, Mulsant BH, Ilyas Kamboh M, Pollock BG, Begley AE, Reynolds CF, DeKosky ST.
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1075-81. PubMed ID: 14677138
    [Abstract] [Full Text] [Related]

  • 10. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
    Laws SM, Hone E, Taddei K, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN.
    Mol Psychiatry; 2002 Dec; 7(8):886-90. PubMed ID: 12232782
    [Abstract] [Full Text] [Related]

  • 11. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
    Korovaĭtseva GI, Shcherbatykh TV, Selezneva NV, Gavrilova SI, Golimbet VE, Voskresenskaia NI, Rogaev EI.
    Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
    [Abstract] [Full Text] [Related]

  • 12. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.
    Neurosci Lett; 2005 Feb 25; 375(1):1-6. PubMed ID: 15664112
    [Abstract] [Full Text] [Related]

  • 13. Molecular genetics of late-onset Alzheimer's disease.
    Kamboh MI.
    Ann Hum Genet; 2004 Jul 25; 68(Pt 4):381-404. PubMed ID: 15225164
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease.
    Bullido MJ, Valdivieso F.
    Microsc Res Tech; 2000 Aug 15; 50(4):261-7. PubMed ID: 10936877
    [Abstract] [Full Text] [Related]

  • 15. [The role of apolipoprotein E in the pathogenesis of Alzheimer disease].
    Okuizumi K.
    Nihon Rinsho; 1999 Dec 15; 57(12):2673-7. PubMed ID: 10638195
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
    Richey PL, Siedlak SL, Smith MA, Perry G.
    Biochem Biophys Res Commun; 1995 Mar 17; 208(2):657-63. PubMed ID: 7695621
    [Abstract] [Full Text] [Related]

  • 17. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
    Huang Y.
    Biochem Soc Trans; 2011 Aug 17; 39(4):924-32. PubMed ID: 21787325
    [Abstract] [Full Text] [Related]

  • 18. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J, Donkin J, Wellington C.
    Biofactors; 2009 Aug 17; 35(3):239-48. PubMed ID: 19472365
    [Abstract] [Full Text] [Related]

  • 19. [Risk factors for Alzheimer's disease].
    Yanagisawa K.
    Rinsho Shinkeigaku; 2000 Dec 17; 40(12):1225-7. PubMed ID: 11464462
    [Abstract] [Full Text] [Related]

  • 20. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P, Caraci F, Copani A, Spada RS, Sortino MA, Salluzzo R, Salemi M, Nicoletti F, Ferri R.
    Neurosci Lett; 2007 Jun 04; 419(3):195-8. PubMed ID: 17498878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.